For the quarter ending 2025-09-30, HLYK had -$9,290 decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -851,800 | -1,751,977 |
| Depreciation and amortization | 20,155 | 55,262 |
| Stock based compensation, including amortization of deferred equity compensation | 53,016 | 12,393 |
| Gain on change in fair value of derivative financial instruments | -2,762 | - |
| Amortization of debt discount | 109,470 | 619,693 |
| (gain) loss on extinguishment of debt | 85,150 | 174,972 |
| Change in fair value of debt | -197,939 | -154,688 |
| Inventory | 4,388 | -17,097 |
| Contract assets | -9,575 | -9,381 |
| Prepaid expenses and other current assets | -15,882 | -29,461 |
| Accounts receivable | - | 0 |
| Right of use lease assets | 33,380 | 122,121 |
| Accounts payable and accrued expenses | 85,886 | 302,982 |
| Lease liability | -33,380 | -123,153 |
| Gain from realization of contingent sale consideration receivable | - | 0 |
| Contract liabilities | -107,477 | -77,333 |
| Gain on change in fair value of derivative financial instruments | - | 45,732 |
| Liabilities held for sale | 64,107 | - |
| Net cash used in operating activities | -444,291 | -850,089 |
| Proceeds from sale of common stock | 0 | 10,000 |
| Acquisition of property and equipment | - | 0 |
| Proceeds from related party notes payable | 556,000 | 710,000 |
| Net cash used in investing activities | - | 0 |
| Proceeds from third party notes payable | 125,000 | 305,000 |
| Repayment of related party notes payable | 56,000 | 0 |
| Repayment of third party notes payable | 189,999 | 230,951 |
| Net cash provided by financing activities | 435,001 | 794,049 |
| Net decrease in cash | -9,290 | -56,040 |
| Cash and cash equivalents at beginning of period | 76,241 | - |
| Cash and cash equivalents at end of period | 10,911 | - |
HealthLynked Corp (HLYK)
HealthLynked Corp (HLYK)